GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 11 filers reported holding GENETIC TECHNOLOGIES LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $26,000 | – | 22,665 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Jump Financial, LLC | 10,657 | $45,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 36,172 | $154,000 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 10,962 | $47,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,483 | $14,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 11,362 | $48,000 | 0.00% |
| Citadel Advisors | 32,900 | $140,000 | 0.00% |
| Citadel Advisors | 29,600 | $126,000 | 0.00% |
| Citadel Advisors | 26,852 | $114,000 | 0.00% |